Mandate

Vinge has advised Rottneros

September 06, 2017

Vinge has advised Rottneros AB (publ) (“Rottneros”) in connection with an issue of unsecured bonds up to a total amount of SEK 600 million.

The bonds have a term of five years and floating interest of STIBOR 3M + 4.15 per cent. Swedbank has acted as financial adviser and sole bookrunner in connection with the bond issue.

The proceeds from the initial bond issue will be used as part of completing the financing of the strategic plan Agenda 500 and for achieving long-term efficiency of the Group's capital structure. The bonds are, in accordance with their terms and conditions, intended to be admitted to trading on the corporate bond list of Nasdaq Stockholm.

Vinge’s team consisted of Louise Salomon together with André Isacson and Lionardo Ojeda.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026